Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

See the follow up and data collection page for details of adverse event reporting.

Suspected Unexpected Serious Adverse Reactions (SUSAR)


SUSAR Q3 2021

SUSAR Q2 2021

SUSAR Q1 2021

SUSAR Q4 2020

SUSAR Q3 2020

SUSAR Q1-2 2020

Annual Reports

Annual Progress Report to Research Ethics Committee 2021

Development Safety Update Report (DSUR) 2021